Assets
608 drug assets in the ADRD landscape.
Each drug asset shows its trial count, geographic footprint, and the mix of outcomes it is measured against. Open any drug asset for the full breakdown.
Every row below is one named therapeutic or investigational drug asset. Imaging agents, procedures, anaesthesia-only agents, challenge probes, generic drug classes, unnamed arms, and other non-therapeutic interventions are excluded.
608 drug assets linked to included trials. Source: ClinicalTrials.gov, as of July 21, 2026.
608 of 608
Donepezil
1,347 endpoints measured
136
Trials
6
Ongoing4%
2,348
Sites
Endpoint mix
+480 other
Memantine
357 endpoints measured
52
Trials
3
Ongoing6%
451
Sites
Endpoint mix
+137 other
Rivastigmine
346 endpoints measured
45
Trials
2
Ongoing4%
841
Sites
Endpoint mix
+123 other
Galantamine
191 endpoints measured
43
Trials
1
Ongoing2%
305
Sites
Endpoint mix
+71 other
Dimebon
157 endpoints measured
23
Trials
1
Ongoing4%
314
Sites
Endpoint mix
+64 other
Lecanemab
155 endpoints measured
19
Trials
17
Ongoing89%
521
Sites
Endpoint mix
+54 other
Donanemab
212 endpoints measured
16
Trials
11
Ongoing69%
670
Sites
Endpoint mix
+51 other
Bapineuzumab
179 endpoints measured
14
Trials
0
Ongoing0%
874
Sites
Endpoint mix
+34 other
Risperidone
58 endpoints measured
14
Trials
0
Ongoing0%
52
Sites
Endpoint mix
+35 other
Rosiglitazone
327 endpoints measured
14
Trials
0
Ongoing0%
507
Sites
Endpoint mix
+132 other
Escitalopram
88 endpoints measured
13
Trials
2
Ongoing15%
54
Sites
Endpoint mix
+39 other
Gantenerumab
492 endpoints measured
13
Trials
1
Ongoing8%
560
Sites
Endpoint mix
+145 other
Levetiracetam
145 endpoints measured
13
Trials
3
Ongoing23%
40
Sites
Endpoint mix
+63 other
Avagacestat
45 endpoints measured
12
Trials
0
Ongoing0%
86
Sites
Endpoint mix
+15 other
Solanezumab
255 endpoints measured
12
Trials
1
Ongoing8%
592
Sites
Endpoint mix
+49 other
Methylphenidate
68 endpoints measured
11
Trials
2
Ongoing18%
18
Sites
Endpoint mix
+29 other
Aducanumab
142 endpoints measured
10
Trials
0
Ongoing0%
634
Sites
Endpoint mix
+37 other
Intepirdine
141 endpoints measured
10
Trials
0
Ongoing0%
477
Sites
Endpoint mix
+50 other
Quetiapine
44 endpoints measured
10
Trials
1
Ongoing10%
62
Sites
Endpoint mix
+24 other
Xanomeline / trospium
177 endpoints measured
10
Trials
10
Ongoing100%
1,326
Sites
Endpoint mix
+89 other
ACC-001
162 endpoints measured
9
Trials
0
Ongoing0%
139
Sites
Endpoint mix
+72 other
Crenezumab
163 endpoints measured
9
Trials
0
Ongoing0%
459
Sites
Endpoint mix
+51 other
CT1812
87 endpoints measured
9
Trials
1
Ongoing11%
121
Sites
Endpoint mix
+42 other
SAM-531
54 endpoints measured
9
Trials
0
Ongoing0%
100
Sites
Endpoint mix
+19 other
Showing 1-24 of 608 assets